16 filings
6-K
SMMT
Summit Therapeutics Inc
26 Dec 19
Current report (foreign)
9:32am
6-K
SMMT
Summit Therapeutics Inc
23 Dec 19
Result of General Meeting, Admission of Fundraising Shares and Directorate Changes
4:06pm
6-K
SMMT
Summit Therapeutics Inc
17 Dec 19
Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended 31 October 2019
8:06am
6-K
SMMT
Summit Therapeutics Inc
6 Dec 19
Current report (foreign)
9:49am
6-K
SMMT
Summit Therapeutics Inc
11 Oct 19
Current report (foreign)
7:50am
6-K
09oe4mo2uil
11 Oct 19
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended 31 July 2019
7:44am
6-K
4iqgsn al
19 Jun 19
Result of Annual General Meeting
4:05pm
6-K
xnifobmk
18 Jun 19
Summit Announces BARDA Increases Award for Ridinilazole Clinical and Regulatory Development to up to $63.7 Million and Exercises Next Contract Option
4:06pm
6-K
4m2pu3
12 Jun 19
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended 30 April 2019
7:32am
6-K
9vugj7o
14 May 19
Publication of UK Annual Report and Notice of Annual General Meeting
5:03pm
6-K
f19r41y1sanre e8
1 Apr 19
Current report (foreign)
4:05pm
6-K
87p98f
27 Mar 19
Summit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2019 and Operational Progress
7:35am
6-K
eve5hgk uy2veqd
13 Feb 19
Current report (foreign)
4:05pm
6-K
23patxa2
14 Jan 19
Award of Restricted Stock Units
4:17pm
6-K
3mvqfs g9f35
10 Jan 19
Completion of $25 million subscription
8:04am
6-K
s1s7ipt
4 Jan 19
Result of General Meeting
4:22pm
- Prev
- 1
- Next